Health Catalyst Inc reports results for the quarter ended in March - Earnings Summary

• Health Catalyst Inc HCAT reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended in March, identical to the same quarter last year. The mean expectation of fifteen analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from -6 cents to 6 cents per share.

• Revenue rose 1.2% to $74.72 million from a year ago; analysts expected $74.80 million.

• Health Catalyst Inc's reported EPS for the quarter was a loss of 35 cents​.

• The company reported a quarterly loss of $20.59 million.

• Health Catalyst Inc shares had fallen by 11.7% this quarter and lost 28.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the software peer group is also "buy"

Wall Street's median 12-month price target for Health Catalyst Inc is $11.50

This summary was machine generated from LSEG data May 9 at 10:39 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)